We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$13.8B
AUM Growth
+$1.18B
Cap. Flow
+$317M
Cap. Flow %
2.3%
Top 10 Hldgs %
23.89%
Holding
1,675
New
92
Increased
753
Reduced
716
Closed
103

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16.8M
2
IBM icon
IBM
IBM
+$10.2M
3
ANSS
Ansys
ANSS
+$8.94M
4
QCOM icon
Qualcomm
QCOM
+$7.56M
5
TSLA icon
Tesla
TSLA
+$6.76M

Sector Composition

Rank Sector Weight
1 Technology 29.82%
2 Consumer Discretionary 8.62%
3 Communication Services 8.47%
4 Healthcare 7.28%
5 Financials 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLF icon
1051
Cleveland-Cliffs
CLF
$6.99B
$698K 0.01%
57,251
+1,686
+3% +$17.7K
COHR icon
1052
Coherent
COHR
$74.2B
$698K 0.01%
6,479
+164
+3% +$16.4K
TCOM icon
1053
Trip.com Group
TCOM
$29.1B
$696K 0.01%
9,251
-429
-4% -$28.7K
FMC icon
1054
FMC
FMC
$1.33B
$695K 0.01%
20,666
+4,648
+29% +$181K
TRMB icon
1055
Trimble
TRMB
$13.9B
$692K 0.01%
8,481
+731
+9% +$59.6K
BEAM icon
1056
Beam Therapeutics
BEAM
$2.84B
$691K 0.01%
28,476
-5,255
-16% -$105K
ETSY icon
1057
Etsy
ETSY
$7.85B
$689K 0.01%
10,373
+2,163
+26% +$129K
WAL icon
1058
Western Alliance Bancorporation
WAL
$8.87B
$686K 0.01%
7,907
-3,523
-31% -$299K
ACAD icon
1059
Acadia Pharmaceuticals
ACAD
$5.03B
$685K 0.01%
32,122
-2,062
-6% -$48.8K
FLEX icon
1060
Flex
FLEX
$44.8B
$684K 0.01%
11,791
+637
+6% +$33.8K
XRAY icon
1061
Dentsply Sirona
XRAY
$2.43B
$683K 0.01%
53,838
+14,012
+35% +$203K
FOLD
1062
DELISTED
Amicus Therapeutics
FOLD
$682K 0.01%
86,608
-13,882
-14% -$98.8K
NOK icon
1063
Nokia
NOK
$52.3B
$675K ﹤0.01%
140,382
+63,057
+82% +$285K
NBB icon
1064
Nuveen Taxable Municipal Income Fund
NBB
$453M
$675K ﹤0.01%
41,608
+10,388
+33% +$165K
ACLX
1065
DELISTED
Arcellx
ACLX
$671K ﹤0.01%
8,172
-1
-0% -$72
ST icon
1066
Sensata Technologies
ST
$6.79B
$670K ﹤0.01%
21,915
-28,713
-57% -$907K
HLN icon
1067
Haleon
HLN
$44.2B
$669K ﹤0.01%
74,539
+8,215
+12% +$79.1K
PLNT icon
1068
Planet Fitness
PLNT
$3.78B
$668K ﹤0.01%
6,440
-34
-0.5% -$3.61K
TWST icon
1069
Twist Bioscience
TWST
$7.25B
$668K ﹤0.01%
23,740
+2,503
+12% +$75.8K
CARR icon
1070
Carrier Global
CARR
$52.8B
$667K ﹤0.01%
11,170
+1,267
+13% +$86.1K
BBN icon
1071
BlackRock Taxable Municipal Bond Trust
BBN
$986M
$667K ﹤0.01%
40,165
-1,315
-3% -$21.3K
DAY
1072
DELISTED
Dayforce
DAY
$666K ﹤0.01%
9,667
-545
-5% -$33.9K
BUD icon
1073
AB InBev
BUD
$165B
$663K ﹤0.01%
11,124
+1,055
+10% +$66.4K
ARCC icon
1074
Ares Capital
ARCC
$14.4B
$661K ﹤0.01%
32,389
-3,112
-9% -$69.2K
COKE icon
1075
Coca-Cola Consolidated
COKE
$12.8B
$656K ﹤0.01%
5,603
-288
-5% -$33.4K

Similar funds

Guggenheim Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Guggenheim Capital held 1,675 positions worth $13.8B, up 9.4% from $12.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Guggenheim Capital's Q3 2025 filing shows 92 new, 753 increased, 716 reduced and 103 closed positions. Its largest new stake was Thomson Reuters: 100,588 shares worth $15.9M. The largest sale was NVIDIA, an estimated $16.8M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Guggenheim Capital's largest Q3 2025 buy was Thomson Reuters: 100,588 shares worth $15.9M.
  • Guggenheim Capital added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $48.1M increase.
  • Guggenheim Capital's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $16.8M.
  • Guggenheim Capital fully exited Ansys in Q3 2025, selling an estimated $8.94M.
  • Guggenheim Capital's ten largest holdings make up 24% of its $13.8B portfolio in Q3 2025.
  • Guggenheim Capital opened 92 new positions and closed 103 in Q3 2025.
  • Guggenheim Capital's portfolio value rose 9.4% quarter-over-quarter to $13.8B.

Based on Guggenheim Capital's 13F filing for Q3 2025, filed 13 Nov 2025.